A multiplexed time-resolved fluorescence resonance energy transfer ultrahigh-throughput screening assay for targeting the SMAD4–SMAD3–DNA complex
Journal of Molecular Cell Biology · 10.04.2024 · 15 (11)
DOI: 10.1093/jmcb/mjad068 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Molecular Cell Biology, online erschienen am 15.11.2023. Verfasst von Wukun Ouyang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA. Hauptthemen laut MEDLINE: Smad4 Protein, Fluorescence Resonance Energy Transfer, High-Throughput Screening Assays, Smad3 Protein. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
The transforming growth factor-beta (TGFβ) signaling pathway plays crucial roles in the establishment of an immunosuppressive tumor microenvironment, making anti-TGFβ agents a significant area of interest in cancer immunotherapy. However, the clinical translation of current anti-TGFβ agents that target upstream cytokines and receptors remains challenging. Therefore, the development of small-molecule inhibitors specifically targeting SMAD4, the downstream master regulator of the TGFβ pathway, would offer an alternative approach with significant therapeutic potential for anti-TGFβ signaling. In this study, we present the development of a cell lysate-based multiplexed time-resolved fluorescence resonance energy transfer (TR-FRET) assay in an ultrahigh-throughput screening (uHTS) 1536-well plate format. This assay enables simultaneous monitoring of the protein‒protein interaction between SMAD4 and SMAD3, as well as the protein‒DNA interaction between SMADs and their consensus DNA-binding motif. The multiplexed TR-FRET assay exhibits high sensitivity, allowing the dynamic analysis of the SMAD4–SMAD3–DNA complex at single-amino acid resolution. Moreover, the multiplexed uHTS assay demonstrates robustness for screening small-molecule inhibitors. Through a pilot screening of an FDA-approved bioactive compound library, we identified gambogic acid and gambogenic acid as potential hit compounds. These proof-of-concept findings underscore the utility of our optimized multiplexed TR-FRET platform for large-scale screening to discover small-molecule inhibitors that target the SMAD4–SMAD3–DNA complex as novel anti-TGFβ signaling agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA.
- Emory Chemical Biology Discovery Center, Emory University School of Medicine, Atlanta, GA 30322, USA.
- Department of Hematology and Medical Oncology and Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA.
Förderung
- NCI NIH HHS
- NIH HHS
- National Cancer Institute
- NCI Emory Lung Cancer
- Career Enhancement Program
- NCI Office of Cancer Genomics Cancer Target Discovery and Development
- NIH
Zitieren
APA
Ouyang, W., Li, Q., Niu, Q., Qui, M., Fu, H., Du, Y., & Mo, X. (2024). A multiplexed time-resolved fluorescence resonance energy transfer ultrahigh-throughput screening assay for targeting the SMAD4–SMAD3–DNA complex. Journal of Molecular Cell Biology, 15(11). https://doi.org/10.1093/jmcb/mjad068
Vancouver
Ouyang W, Li Q, Niu Q, Qui M, Fu H, Du Y, et al. A multiplexed time-resolved fluorescence resonance energy transfer ultrahigh-throughput screening assay for targeting the SMAD4–SMAD3–DNA complex. Journal of Molecular Cell Biology. 2024;15(11). doi:10.1093/jmcb/mjad068
BibTeX
@article{Ouyang2024,
author = {Ouyang, Wukun and Li, Qianjin and Niu, Qiankun and Qui, Min and Fu, Haian and Du, Yuhong and Mo, Xiulei},
title = {A multiplexed time-resolved fluorescence resonance energy transfer ultrahigh-throughput screening assay for targeting the SMAD4–SMAD3–DNA complex},
journal = {Journal of Molecular Cell Biology},
year = {2024},
volume = {15},
number = {11},
doi = {10.1093/jmcb/mjad068}
}
EUVIMED